Tyrosine kinase inhibitors
Details for Australian Patent Application No. 2003231747 (hide)
International Classifications
Event Publications
28 August 2003 Complete Application Filed
Priority application(s): 60/372,358 12.04.02 US
4 December 2003 Application Open to Public Inspection
Published as AU-B-2003231747
18 September 2008 Application Accepted
Published as AU-B-2003231747
22 January 2009 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003231748-DEVICE AND METHOD TO EXPAND OPERATING RANGE OF A FUEL CELL STACK
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser